By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Oral nutritional supplements > Dojolvi
Oral nutritional supplements

Dojolvi

https://themeditary.com/drug/dojolvi-4019.html
Medically Reviewed by Judith Stewart, BPharm TheMediTary.Com | Reviewed: Aug 05, 2023  Additional Content by TheMediTary.Com

Generic name: triheptanoin [ trye-hep-ta-noyn ]

Drug class: Oral nutritional supplements

Dosage form: oral liquid

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Triheptanoin

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Dojolvi?

Dojolvi is a synthetic is a medium chain triglyceride containing three odd-chain fatty acid molecules.

Dojolvi is a prescription medicine used to treat long-chain fatty acid oxidation disorders in adults and children.

Long-chain fatty acid oxidation disorders are rare genetic disorders that affect the body's ability to break down certain fats and convert them into energy. This can lead to low blood sugar, muscle weakness, heart problems, or life-threatening medical problems.

Warnings

Before taking Dojolvi, tell your healthcare provider if you are taking a pancreatic lipase inhibitor, such as orlistat (Xenical), as it may affect how well Dojolvi works.

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

Before taking this medicine

To make sure Dojolvi is safe for you, tell your doctor if you have ever had: problems with your pancreas. Dojolvi may not work as well if your digestion is affected by a pancreas disorder.

Tell your doctor if you are pregnant or breastfeeding.

If you are pregnant, you may be enrolled in a pregnancy safety study to track the effects of triheptanoin on the baby.

Dojolvi pregnancy and breastfeeding warnings (more detail)

How should I take Dojolvi

Take Dojolvi exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose.

If you are taking another medium chain triglyceride product, stop taking it before you start taking Dojolvi.

Dojolvi is usually taken at least 4 times per day with meals or snacks. Follow your doctor's dosing instructions very carefully.

Dojolvi should always be mixed well with liquid or soft food. Do not take the medicine alone or it may upset your stomach. Examples of what to mix this medicine with include:

  • fat-free yogurt (plain or flavored);

  • fat-free pudding or smoothies;

  • low-sugar applesauce;

  • fat-free cottage cheese;

  • skim (fat-free) milk;

  • fat-free baby food; or

  • whole grain hot cereal.

Read and carefully follow all instructions about mixing Dojolvi with liquid or soft foods, or how to mix and give the medicine through a feeding tube. Ask your doctor or pharmacist if you do not understand these instructions.

Always mix the medicine in a clean container.

Do not mix or store Dojolvi in any syringe, container or cup made of polystyrene plastic or polyvinyl chloride (PVC). Do not give this medicine through a feeding tube made of PVC.

You may have problems with your feeding tube the longer you keep using Dojolvi. Check your feeding tube frequently to make sure it is working properly.

You may need to follow a special diet while using Dojolvi. Follow all instructions of your doctor or dietitian. Learn about the foods to eat or avoid to help control your condition. You may also need to track the number of calories you consume each day while taking Dojolvi.

Store Dojolvi in the original container at room temperature, away from moisture and heat. Do not freeze.

Store mixed medicine in the refrigerator and use it within 24 hours.

Throw away any unused Dojolvi 90 days after you first opened the bottle or on the expiration date (whichever comes first).

Dosing information

Usual Adult Dose of Dojolvi for Functional Gastric Disorder:

Recommended total daily dose (mL) = patients DCI (kcal) x target % dose of DCI / 8.3 kcal/mL
-Round to nearest whole number
-Divide total daily dose into at least 4 approximately equal individual doses


Dose Initiation/Titration:

Patients not currently taking a medium chain triglyceride (MCT) product:
-Initiate at approximately 10% DCI divided into at least 4 individual doses.
-Increase to recommended total daily dose over 2 to 3 weeks.

Patients switching from another MCT product:
-Discontinue previous MCT before therapy initiation.
-Initiate at last tolerated MCT dose divided into at least 4 individual doses.
-Increase total daily dosage by approximately 5% DCI every 2 to 3 days until target dosage is achieved.


Comments:
-Assess metabolic requirements by determining daily caloric intake (DCI) prior to dose calculations.
-Recommended target is 35% of DCI.
-Caloric value of this product is 8.3 kcal/mL.

Usual Pediatric Dose of Dojolvi for Functional Gastric Disorder:

Recommended total daily dose (mL) = patients DCI (kcal) x target % dose of DCI / 8.3 kcal/mL
-Round to nearest whole number
-Divide total daily dose into at least 4 approximately equal individual doses


Dose Initiation/Titration:

Patients not currently taking a medium chain triglyceride (MCT) product:
-Initiate at approximately 10% DCI divided into at least 4 individual doses.
-Increase to recommended total daily dose over 2 to 3 weeks.

Patients switching from another MCT product:
-Discontinue previous MCT before therapy initiation.
-Initiate at last tolerated MCT dose divided into at least 4 individual doses.
-Increase total daily dosage by approximately 5% DCI every 2 to 3 days until target dosage is achieved.


Comments:
-Assess metabolic requirements by determining daily caloric intake (DCI) prior to dose calculations.
-Recommended target is 35% of DCI.
-Caloric value of this product is 8.3 kcal/mL.
-Neonates may require a higher fat intake and thus an increased dose of this product; consider current nutritional recommendations when dosing in this population.

Detailed Dojolvi dosage information
Dojolvi Dosage information (more detail)

Before Taking

To make sure Dojolvi is safe for you, tell your doctor if you have ever had: problems with your pancreas. Dojolvi may not work as well if your digestion is affected by a pancreas disorder.

Tell your doctor if you are pregnant or breastfeeding.

If you are pregnant, you may be enrolled in a pregnancy safety study to track the effects of triheptanoin on the baby.

Dojolvi pregnancy and breastfeeding warnings (more detail)

Related/similar drugs

triheptanoin

What happens if I miss a dose?

Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Then take the rest of the day's doses every 3 to 4 hours.

Skip the missed dose if you cannot take all 4 doses in one day. Do not take two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Dojolvi?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Dojolvi side effects

Get emergency medical help if you have signs of an allergic reaction to Dojolvi: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Common Dojolvi side effects may include:

  • nausea, vomiting;

  • stomach pain; or

  • diarrhea.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Dojolvi Side Effects

What other drugs will affect Dojolvi?

Tell your doctor about all your other medicines, especially:

  • orlistat (alli, Xenical).

This list is not complete. Other drugs may interact with triheptanoin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

More about Dojolvi (Triheptanoin [ trye-hep-ta-noyn ])

Dosage information
Dojolvi Side Effects
During pregnancy
Dojolvi Prescribing Information
Drug images
Side effects
Drug class: Oral nutritional supplements

Related treatment guides

Long-Chain Fatty Acid Oxidation Disorders
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by